Similar articles

• Irinotecan/5-fluorouracil/leucovorin in advanced colorectal cancer: Oncologic Drugs Advisory committee summary.

  Oncologic Drugs Advisory Committee. Oncologic Drugs Advisory Committee. Clin Colorectal Cancer. 2002 May;2(1):8-10. Clin Colorectal Cancer. 2002. PMID: 12453328 No abstract available.
• Lessons learned from the Saltz and Mayo Clinic regimens.

  Chu E. Chu E. Clin Colorectal Cancer. 2002 May;2(1):13. doi: 10.1016/S1533-0028(11)70496-0. Clin Colorectal Cancer. 2002. PMID: 12453330 No abstract available.
• [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].

  Motomura S. Motomura S. Nihon Rinsho. 2003 Sep;61 Suppl 7:360-3. Nihon Rinsho. 2003. PMID: 14574913 Review. Japanese. No abstract available.
• [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].

  Guan ZZ. Guan ZZ. Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):718-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274384 Review. Chinese. No abstract available.
• Irinotecan as first-line treatment of colorectal cancer: new indication. A modest advantage.

  [No authors listed] [No authors listed] Prescrire Int. 2001 Apr;10(52):41-3. Prescrire Int. 2001. PMID: 11718156